OMDA · Omada Health, Inc.
$24.04
-0.33 (-1.35%)
At close · Aug 14
Market Cap
$1.47B
Shares
61.22M
Omada Health, Inc. Earnings Call Transcripts
Every quarterly earnings call for Omada Health, Inc. (OMDA) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Capital Markets Day
Investor event
2026-09-10
Omada Health Investor Day 2026
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-08-11
Canaccord Genuity’s 46th Annual Growth Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-06
Omada Health Second Quarter 2026 Earnings
Confident tone
PBM and HCSC Channel Expansion
Operating Efficiency
Cholesterol Product Launch
Revenue
$87.83M
▲ 43.1% YoY Diluted EPS
$0.08
Gross margin
72.6%
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-10
Goldman Sachs 47th Annual Global Healthcare Conference 2026
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-07
Omada Health, Inc. Q1 FY2026 Earnings Call
Confident tone
GLP-1 capabilities and channel expansion
Enrollment and conversion
Reach and employer relationships
Revenue
$78.05M
▲ 42% YoY Diluted EPS
$-0.05
Gross margin
62.4%
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-05
Omada Health, Inc. Q4 FY2025 Earnings Call
Confident tone
GLP-1 Care Track and GLP-1 Ecosystem
Multi-Condition Platform Expansion
First Quarter of GAAP Profitability
Revenue
$75.85M*
Gross margin
70.8%
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Omada Health, Inc. Q3 FY2025 Earnings Call
Confident tone
Revenue and membership growth
GLP-1 strategy and prescribing
Multi-product / multi-condition platform
Revenue
$68.03M
▲ 49.5% YoY Diluted EPS
$-0.06
Gross margin
66.3%
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Omada Health, Inc. Q2 FY2025 Earnings Call
Revenue
$61.37M
▲ 48.9% YoY Diluted EPS
$-0.24
Gross margin
65.7%
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–8 of 8 earnings calls
Key facts
CIK
1611115
CUSIP
68170A108
13F (30d)
145 filings
144 filers
Visit website
Investor relations